Atypical Parkinsonian Syndromes

munich aps 2019

Atypical Parkinsonian Syndromes
Munich, Germany – May 17-18, 2019

Atypical parkinsonian syndromes takes place in Munich, Germany, May 17-18, 2019.Course Directors

Günter Höglinger DZNE / TUM Munich, Germany
Gregor Wenning University Innsbruck, Austria

Course Description

Atypical parkinsonian syndromes are a group of hypokinetic neurodegenerative diseases other than Parkinson’s disease. Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD), Multiple System Atrophy (MSA) and Dementia with Lewy Bodies (DLB) are the most prominent representatives of this group. Movement Disorder specialists require specific expertise and skills for adequate medical care for patients with atypical parkinsonian syndromes. International research efforts make atypical parkinsonian syndromes particularly attractive for young neurologists.

This course is designed to provide young neurologist and future experts in Movement Disorders the essential knowledge and skills required for qualified medical care and high end research in atypical parkinsonian syndromes. Participants will attend lectures presenting the different disease entities, followed by clinical skills lectures focusing on the clinical identification specific signs and symptoms. Then participants will have the opportunity to examine individual patients with atypical parkinsonian syndromes. There will be plenty of opportunities to engage in a constructive discussions with the international experts. Attendees are also encouraged to bring own case-study videos and discuss them with faculty.

A working knowledge of English is required.

Recommended Audience

Young neurologists with an expertise in movement disorders.

Learning Objectives 

Upon completion of this program, participants will be able to:

  • Identify clinical signs and symptoms alerting for the possible presence of atypical parkinsonism
  • Apply detailed clinical examination skills to diagnose atypical parkinsonism
  • Demonstrate the scientific concept and clinical application of diagnostic criteria
  • Evaluate the additional clinical examination content for atypical parkinsonism
  • Select adequate treatment strategies for atypical parkinsonism

Venue

German Center for Neurodegenerative Diseases (DZNE)
Feodor-Lynen-Strasse 17
81377 Munich
Germany

EACCME Credits – Accreditation Statement

The MDS-ES Atypical Parkinsonian Syndromes, Munich, Germany, 17/05/2019-18/05/2019 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 11 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found on the AMA website.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

Visa Statement

MDS is able to provide participants with a Letter of Support and any course-related documentation needed to assist in obtaining a visa. Please note that MDS is unable to contact the Embassy on your behalf. It is the responsibility of each participant to make the necessary arrangements related to this process. However, if the official handling your application needs further clarification, please have them contact education@movementdisorders.org

 


Atypical Parkinsonian Syndromes is compliant with MedTech Europe Code of Ethical Business Practice.

Top

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice